World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
24683
World Ranking
15632
National Ranking
74

Research.com Recognitions

  • Member of the Norwegian Academy of Science and Letters Medicine
  • Member of the Norwegian Academy of Science and Letters Medicine

Overview

Anders Waage is affiliated with the Norwegian University of Science and Technology in Norway. Their research mainly spans the fields of medicine and biochemistry, genetics, and molecular biology, with a significant focus on hematology, molecular biology, oncology, genetics, and cancer research.

The core of Waage's research topics revolves around multiple myeloma research and treatments, with additional interests including protein degradation and inhibitors, peptidase inhibition and analysis, cancer treatment and pharmacology, ubiquitin and proteasome pathways, bone health and treatments, and myeloproliferative neoplasms: diagnosis and treatment.

Waage has contributed to numerous publications in various scientific venues. The frequent publication outlets include:

  • Blood
  • Blood Cancer Journal
  • HemaSphere
  • Clinical Lymphoma Myeloma & Leukemia
  • British Journal of Haematology

Some recent significant papers featuring Waage's work are:

  • Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study, published in 2020 in The Lancet Haematology
  • Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project, published in 2022 in the Journal of Clinical Oncology
  • Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group, published in 2021 in The Lancet Oncology
  • Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations, published in 2021 in British Journal of Haematology
  • Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report, published in 2021 in Blood Cancer Journal

Frequent co-authors collaborating with Waage include:

  • Pieter Sonneveld
  • Sonja Zweegman
  • Markus Hansson
  • Fredrik Schjesvold
  • Tobias S. Slørdahl

Waage has been involved in 97 publications related to medicine and 43 in biochemistry, genetics, and molecular biology. Within these, Waage contributed to 52 works in hematology, 36 in molecular biology, 26 in oncology, 7 in genetics, and 5 in cancer research, reflecting a broad and specialized focus on blood cancers and molecular mechanisms underlying these diseases.

Among the research topics Waage covers, the most prominent is multiple myeloma research and treatments, with 88 publications; other notable topics include protein degradation and inhibitors (48 publications), peptidase inhibition and analysis (18), cancer treatment and pharmacology (16), ubiquitin and proteasome pathways (10), bone health and treatments (10), and myeloproliferative neoplasms diagnosis and treatment (6).

Waage is a member of the Norwegian Academy of Science and Letters in the field of medicine.

Best Publications

  • The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.

    A Waage;P Brandtzaeg;A Halstensen;P Kierulf

  • Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.

    A. Waage;A. Halstensen;T. Espevik

  • Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma

    Bhairavi Swaminathan;Guðmar Thorleifsson;Magnus Jöud;Mina Ali

  • Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

    A. Palumbo;S. V. Rajkumar;M. A. Dimopoulos;P. G. Richardson

  • Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response.

    A Waage;A Halstensen;R Shalaby;P Brandtzaeg

  • Inflammatory Response After Open Heart Surgery: Release of Heat-Shock Protein 70 and Signaling Through Toll-Like Receptor-4

    Brit Dybdahl;Alexander Wahba;Egil Lien;Trude H. Flo

  • Endotoxin, tumor necrosis factor-α and interleukin 1 induce interleukin 6 production in vivo

    M.R. Shalaby;A. Waage;L. Aarden;T. Espevik

  • Thalidomide for treatment of multiple myeloma: 10 years later

    Antonio Palumbo;Thierry Facon;Pieter Sonneveld;Joan Bladè

  • Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy

    Sissel Linda Opsjøn;Neville C. Wathen;Solveig Tingulstad;Gro Wiedswang

  • Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice.

    Anders Waage;Terje Espevik

  • Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials

    Peter M. Fayers;Peter M. Fayers;Antonio Palumbo;Cyrille Hulin;Anders Waage

  • Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study

    Michele Cavo;Meral Beksac;Lucia Pantani

  • Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data

    Antonio Palumbo;Sara Bringhen;Shaji K Kumar;Giulia Lupparelli

  • Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells

    Therese Standal;Carina Seidel;Øyvind Hjertner;Torben Plesner

  • Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma

    Anders Waage;Peter Gimsing;Peter Fayers;Peter Fayers;Niels Abildgaard

  • Serum syndecan-1: a new independent prognostic marker in multiple myeloma.

    Carina Seidel;Anders Sundan;Martin Hjorth;Ingemar Turesson

  • GLUCOCORTICOIDS INHIBIT THE PRODUCTION OF IL6 FROM MONOCYTES, ENDOTHELIAL CELLS AND FIBROBLASTS

    Anders Waage;Geir Slupphaug;Refaat Shalaby

  • Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group.

    C Seidel;M Børset;I Turesson;N Abildgaard

  • The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network.

    E Terpos;E Terpos;O Sezer;P. I Croucher;R Garcia-Sanz

  • ORIGINAL ARTICLE Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

    A Palumbo;SV Rajkumar;MA Dimopoulos;PG Richardson

Frequent Co-Authors

Anders Sundan
Anders Sundan Norwegian University of Science and Technology
Pieter Sonneveld
Pieter Sonneveld Erasmus University Rotterdam
Sonja Zweegman
Sonja Zweegman Amsterdam UMC
Terje Espevik
Terje Espevik Norwegian University of Science and Technology
Michele Cavo
Michele Cavo University of Bologna
Roman Hájek
Roman Hájek University of Ostrava
Antonio Palumbo
Antonio Palumbo University of Turin
Mario Boccadoro
Mario Boccadoro University of Turin
Meletios A. Dimopoulos
Meletios A. Dimopoulos National and Kapodistrian University of Athens
Björn Nilsson
Björn Nilsson Lund University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring a career in Medicine in the USA, there are several alternative pathways and online degrees that can help you enter healthcare roles or advance your career. Many students seek the cheapest dnp programs online to become nurse practitioners or nurse leaders, offering flexibility and affordability compared to traditional programs.

Those interested in pharmacy careers can choose among accredited online pharmacist programs, which prepare graduates for pharmaceutical practice and research. For students leaning toward healthcare administration or data roles, earning an online mhi (Master’s in Health Information) offers a pathway into digital health and medical data management.

Entry-level opportunities are also expanding, with credentialing options like medical billing and coding classes online. These classes are ideal for those seeking quick entry into the healthcare sector without pursuing extended medical study.

With the increasing availability of online healthcare degrees, more students can access flexible, accredited options to match their career goals and personal circumstances.

Best Scientists Citing Anders Waage

Trending Scientists